Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for prevention of renal scarring in pyelonephritis
IRCT20241105063602N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in pyelonephritis and kidney fibrosis, sponsored by Qom University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
pyelonephritiskidney fibrosis
Beyond the preview
Go deeper on IRCT20241105063602N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241105063602N1.